Click for best price
Living Biological Drugs Market Size, Share 2023
This report contains market size and forecasts of Living Biological Drugs in Global, including the following market information:
Global Living Biological Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Living Biological Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Single Strain Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Living Biological Drugs include Ardeypharman, Miyarisan Pharmaceutical, Ferring Pharmaceuticals, Seres Therapeutics, Infant Bacterial Therapeutics, Osel, Takeda, AOBiome and Synlogic, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Living Biological Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Living Biological Drugs Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Living Biological Drugs Market Segment Percentages, by Type, 2022 (%)
Single Strain
Multi Strain
Co-Culture
Global Living Biological Drugs Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Living Biological Drugs Market Segment Percentages, by Application, 2022 (%)
Digestive System
Urinary System
Skin System
Global Living Biological Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Living Biological Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Living Biological Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Living Biological Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ardeypharman
Miyarisan Pharmaceutical
Ferring Pharmaceuticals
Seres Therapeutics
Infant Bacterial Therapeutics
Osel
Takeda
AOBiome
Synlogic
Finch Therapeutics
Capsugel
Jeneil Biotech
UAS Labs
Biose
Cerbios-Pharma
Inpac Probiotics
NIZO
Winclove Probiotics
BJP Laboratories
Luina Bio
List Labs
MatriSys Bioscience
| Report Attributes |
Report Details |
| Report Title |
Living Biological Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
115 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Living Biological Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Living Biological Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Living Biological Drugs Overall Market Size
2.1 Global Living Biological Drugs Market Size: 2022 VS 2030
2.2 Global Living Biological Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Living Biological Drugs Players in Global Market
3.2 Top Global Living Biological Drugs Companies Ranked by Revenue
3.3 Global Living Biological Drugs Revenue by Companies
3.4 Top 3 and Top 5 Living Biological Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Living Biological Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Living Biological Drugs Players in Global Market
3.6.1 List of Global Tier 1 Living Biological Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Living Biological Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Living Biological Drugs Market Size Markets, 2022 & 2030
4.1.2 Single Strain
4.1.3 Multi Strain
4.1.4 Co-Culture
4.2 By Type - Global Living Biological Drugs Revenue & Forecasts
4.2.1 By Type - Global Living Biological Drugs Revenue, 2018-2023
4.2.2 By Type - Global Living Biological Drugs Revenue, 2023-2030
4.2.3 By Type - Global Living Biological Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Living Biological Drugs Market Size, 2022 & 2030
5.1.2 Digestive System
5.1.3 Urinary System
5.1.4 Skin System
5.2 By Application - Global Living Biological Drugs Revenue & Forecasts
5.2.1 By Application - Global Living Biological Drugs Revenue, 2018-2023
5.2.2 By Application - Global Living Biological Drugs Revenue, 2023-2030
5.2.3 By Application - Global Living Biological Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Living Biological Drugs Market Size, 2022 & 2030
6.2 By Region - Global Living Biological Drugs Revenue & Forecasts
6.2.1 By Region - Global Living Biological Drugs Revenue, 2018-2023
6.2.2 By Region - Global Living Biological Drugs Revenue, 2023-2030
6.2.3 By Region - Global Living Biological Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Living Biological Drugs Revenue, 2018-2030
6.3.2 US Living Biological Drugs Market Size, 2018-2030
6.3.3 Canada Living Biological Drugs Market Size, 2018-2030
6.3.4 Mexico Living Biological Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Living Biological Drugs Revenue, 2018-2030
6.4.2 Germany Living Biological Drugs Market Size, 2018-2030
6.4.3 France Living Biological Drugs Market Size, 2018-2030
6.4.4 U.K. Living Biological Drugs Market Size, 2018-2030
6.4.5 Italy Living Biological Drugs Market Size, 2018-2030
6.4.6 Russia Living Biological Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Living Biological Drugs Market Size, 2018-2030
6.4.8 Benelux Living Biological Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Living Biological Drugs Revenue, 2018-2030
6.5.2 China Living Biological Drugs Market Size, 2018-2030
6.5.3 Japan Living Biological Drugs Market Size, 2018-2030
6.5.4 South Korea Living Biological Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Living Biological Drugs Market Size, 2018-2030
6.5.6 India Living Biological Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Living Biological Drugs Revenue, 2018-2030
6.6.2 Brazil Living Biological Drugs Market Size, 2018-2030
6.6.3 Argentina Living Biological Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Living Biological Drugs Revenue, 2018-2030
6.7.2 Turkey Living Biological Drugs Market Size, 2018-2030
6.7.3 Israel Living Biological Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Living Biological Drugs Market Size, 2018-2030
6.7.5 UAE Living Biological Drugs Market Size, 2018-2030
7 Players Profiles
7.1 Ardeypharman
7.1.1 Ardeypharman Corporate Summary
7.1.2 Ardeypharman Business Overview
7.1.3 Ardeypharman Living Biological Drugs Major Product Offerings
7.1.4 Ardeypharman Living Biological Drugs Revenue in Global Market (2018-2023)
7.1.5 Ardeypharman Key News
7.2 Miyarisan Pharmaceutical
7.2.1 Miyarisan Pharmaceutical Corporate Summary
7.2.2 Miyarisan Pharmaceutical Business Overview
7.2.3 Miyarisan Pharmaceutical Living Biological Drugs Major Product Offerings
7.2.4 Miyarisan Pharmaceutical Living Biological Drugs Revenue in Global Market (2018-2023)
7.2.5 Miyarisan Pharmaceutical Key News
7.3 Ferring Pharmaceuticals
7.3.1 Ferring Pharmaceuticals Corporate Summary
7.3.2 Ferring Pharmaceuticals Business Overview
7.3.3 Ferring Pharmaceuticals Living Biological Drugs Major Product Offerings
7.3.4 Ferring Pharmaceuticals Living Biological Drugs Revenue in Global Market (2018-2023)
7.3.5 Ferring Pharmaceuticals Key News
7.4 Seres Therapeutics
7.4.1 Seres Therapeutics Corporate Summary
7.4.2 Seres Therapeutics Business Overview
7.4.3 Seres Therapeutics Living Biological Drugs Major Product Offerings
7.4.4 Seres Therapeutics Living Biological Drugs Revenue in Global Market (2018-2023)
7.4.5 Seres Therapeutics Key News
7.5 Infant Bacterial Therapeutics
7.5.1 Infant Bacterial Therapeutics Corporate Summary
7.5.2 Infant Bacterial Therapeutics Business Overview
7.5.3 Infant Bacterial Therapeutics Living Biological Drugs Major Product Offerings
7.5.4 Infant Bacterial Therapeutics Living Biological Drugs Revenue in Global Market (2018-2023)
7.5.5 Infant Bacterial Therapeutics Key News
7.6 Osel
7.6.1 Osel Corporate Summary
7.6.2 Osel Business Overview
7.6.3 Osel Living Biological Drugs Major Product Offerings
7.6.4 Osel Living Biological Drugs Revenue in Global Market (2018-2023)
7.6.5 Osel Key News
7.7 Takeda
7.7.1 Takeda Corporate Summary
7.7.2 Takeda Business Overview
7.7.3 Takeda Living Biological Drugs Major Product Offerings
7.7.4 Takeda Living Biological Drugs Revenue in Global Market (2018-2023)
7.7.5 Takeda Key News
7.8 AOBiome
7.8.1 AOBiome Corporate Summary
7.8.2 AOBiome Business Overview
7.8.3 AOBiome Living Biological Drugs Major Product Offerings
7.8.4 AOBiome Living Biological Drugs Revenue in Global Market (2018-2023)
7.8.5 AOBiome Key News
7.9 Synlogic
7.9.1 Synlogic Corporate Summary
7.9.2 Synlogic Business Overview
7.9.3 Synlogic Living Biological Drugs Major Product Offerings
7.9.4 Synlogic Living Biological Drugs Revenue in Global Market (2018-2023)
7.9.5 Synlogic Key News
7.10 Finch Therapeutics
7.10.1 Finch Therapeutics Corporate Summary
7.10.2 Finch Therapeutics Business Overview
7.10.3 Finch Therapeutics Living Biological Drugs Major Product Offerings
7.10.4 Finch Therapeutics Living Biological Drugs Revenue in Global Market (2018-2023)
7.10.5 Finch Therapeutics Key News
7.11 Capsugel
7.11.1 Capsugel Corporate Summary
7.11.2 Capsugel Business Overview
7.11.3 Capsugel Living Biological Drugs Major Product Offerings
7.11.4 Capsugel Living Biological Drugs Revenue in Global Market (2018-2023)
7.11.5 Capsugel Key News
7.12 Jeneil Biotech
7.12.1 Jeneil Biotech Corporate Summary
7.12.2 Jeneil Biotech Business Overview
7.12.3 Jeneil Biotech Living Biological Drugs Major Product Offerings
7.12.4 Jeneil Biotech Living Biological Drugs Revenue in Global Market (2018-2023)
7.12.5 Jeneil Biotech Key News
7.13 UAS Labs
7.13.1 UAS Labs Corporate Summary
7.13.2 UAS Labs Business Overview
7.13.3 UAS Labs Living Biological Drugs Major Product Offerings
7.13.4 UAS Labs Living Biological Drugs Revenue in Global Market (2018-2023)
7.13.5 UAS Labs Key News
7.14 Biose
7.14.1 Biose Corporate Summary
7.14.2 Biose Business Overview
7.14.3 Biose Living Biological Drugs Major Product Offerings
7.14.4 Biose Living Biological Drugs Revenue in Global Market (2018-2023)
7.14.5 Biose Key News
7.15 Cerbios-Pharma
7.15.1 Cerbios-Pharma Corporate Summary
7.15.2 Cerbios-Pharma Business Overview
7.15.3 Cerbios-Pharma Living Biological Drugs Major Product Offerings
7.15.4 Cerbios-Pharma Living Biological Drugs Revenue in Global Market (2018-2023)
7.15.5 Cerbios-Pharma Key News
7.16 Inpac Probiotics
7.16.1 Inpac Probiotics Corporate Summary
7.16.2 Inpac Probiotics Business Overview
7.16.3 Inpac Probiotics Living Biological Drugs Major Product Offerings
7.16.4 Inpac Probiotics Living Biological Drugs Revenue in Global Market (2018-2023)
7.16.5 Inpac Probiotics Key News
7.17 NIZO
7.17.1 NIZO Corporate Summary
7.17.2 NIZO Business Overview
7.17.3 NIZO Living Biological Drugs Major Product Offerings
7.17.4 NIZO Living Biological Drugs Revenue in Global Market (2018-2023)
7.17.5 NIZO Key News
7.18 Winclove Probiotics
7.18.1 Winclove Probiotics Corporate Summary
7.18.2 Winclove Probiotics Business Overview
7.18.3 Winclove Probiotics Living Biological Drugs Major Product Offerings
7.18.4 Winclove Probiotics Living Biological Drugs Revenue in Global Market (2018-2023)
7.18.5 Winclove Probiotics Key News
7.19 BJP Laboratories
7.19.1 BJP Laboratories Corporate Summary
7.19.2 BJP Laboratories Business Overview
7.19.3 BJP Laboratories Living Biological Drugs Major Product Offerings
7.19.4 BJP Laboratories Living Biological Drugs Revenue in Global Market (2018-2023)
7.19.5 BJP Laboratories Key News
7.20 Luina Bio
7.20.1 Luina Bio Corporate Summary
7.20.2 Luina Bio Business Overview
7.20.3 Luina Bio Living Biological Drugs Major Product Offerings
7.20.4 Luina Bio Living Biological Drugs Revenue in Global Market (2018-2023)
7.20.5 Luina Bio Key News
7.21 List Labs
7.21.1 List Labs Corporate Summary
7.21.2 List Labs Business Overview
7.21.3 List Labs Living Biological Drugs Major Product Offerings
7.21.4 List Labs Living Biological Drugs Revenue in Global Market (2018-2023)
7.21.5 List Labs Key News
7.22 MatriSys Bioscience
7.22.1 MatriSys Bioscience Corporate Summary
7.22.2 MatriSys Bioscience Business Overview
7.22.3 MatriSys Bioscience Living Biological Drugs Major Product Offerings
7.22.4 MatriSys Bioscience Living Biological Drugs Revenue in Global Market (2018-2023)
7.22.5 MatriSys Bioscience Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Living Biological Drugs Market Opportunities & Trends in Global Market
Table 2. Living Biological Drugs Market Drivers in Global Market
Table 3. Living Biological Drugs Market Restraints in Global Market
Table 4. Key Players of Living Biological Drugs in Global Market
Table 5. Top Living Biological Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Living Biological Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Living Biological Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Living Biological Drugs Product Type
Table 9. List of Global Tier 1 Living Biological Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Living Biological Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Living Biological Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Living Biological Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Living Biological Drugs Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Living Biological Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Living Biological Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Living Biological Drugs Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Living Biological Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Living Biological Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Living Biological Drugs Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Living Biological Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Living Biological Drugs Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Living Biological Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Living Biological Drugs Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Living Biological Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Living Biological Drugs Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Living Biological Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Living Biological Drugs Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Living Biological Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Living Biological Drugs Revenue, (US$, Mn), 2023-2030
Table 30. Ardeypharman Corporate Summary
Table 31. Ardeypharman Living Biological Drugs Product Offerings
Table 32. Ardeypharman Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 33. Miyarisan Pharmaceutical Corporate Summary
Table 34. Miyarisan Pharmaceutical Living Biological Drugs Product Offerings
Table 35. Miyarisan Pharmaceutical Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 36. Ferring Pharmaceuticals Corporate Summary
Table 37. Ferring Pharmaceuticals Living Biological Drugs Product Offerings
Table 38. Ferring Pharmaceuticals Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 39. Seres Therapeutics Corporate Summary
Table 40. Seres Therapeutics Living Biological Drugs Product Offerings
Table 41. Seres Therapeutics Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 42. Infant Bacterial Therapeutics Corporate Summary
Table 43. Infant Bacterial Therapeutics Living Biological Drugs Product Offerings
Table 44. Infant Bacterial Therapeutics Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 45. Osel Corporate Summary
Table 46. Osel Living Biological Drugs Product Offerings
Table 47. Osel Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 48. Takeda Corporate Summary
Table 49. Takeda Living Biological Drugs Product Offerings
Table 50. Takeda Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 51. AOBiome Corporate Summary
Table 52. AOBiome Living Biological Drugs Product Offerings
Table 53. AOBiome Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 54. Synlogic Corporate Summary
Table 55. Synlogic Living Biological Drugs Product Offerings
Table 56. Synlogic Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 57. Finch Therapeutics Corporate Summary
Table 58. Finch Therapeutics Living Biological Drugs Product Offerings
Table 59. Finch Therapeutics Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 60. Capsugel Corporate Summary
Table 61. Capsugel Living Biological Drugs Product Offerings
Table 62. Capsugel Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 63. Jeneil Biotech Corporate Summary
Table 64. Jeneil Biotech Living Biological Drugs Product Offerings
Table 65. Jeneil Biotech Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 66. UAS Labs Corporate Summary
Table 67. UAS Labs Living Biological Drugs Product Offerings
Table 68. UAS Labs Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 69. Biose Corporate Summary
Table 70. Biose Living Biological Drugs Product Offerings
Table 71. Biose Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 72. Cerbios-Pharma Corporate Summary
Table 73. Cerbios-Pharma Living Biological Drugs Product Offerings
Table 74. Cerbios-Pharma Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 75. Inpac Probiotics Corporate Summary
Table 76. Inpac Probiotics Living Biological Drugs Product Offerings
Table 77. Inpac Probiotics Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 78. NIZO Corporate Summary
Table 79. NIZO Living Biological Drugs Product Offerings
Table 80. NIZO Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 81. Winclove Probiotics Corporate Summary
Table 82. Winclove Probiotics Living Biological Drugs Product Offerings
Table 83. Winclove Probiotics Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 84. BJP Laboratories Corporate Summary
Table 85. BJP Laboratories Living Biological Drugs Product Offerings
Table 86. BJP Laboratories Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 87. Luina Bio Corporate Summary
Table 88. Luina Bio Living Biological Drugs Product Offerings
Table 89. Luina Bio Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 90. List Labs Corporate Summary
Table 91. List Labs Living Biological Drugs Product Offerings
Table 92. List Labs Living Biological Drugs Revenue (US$, Mn), (2018-2023)
Table 93. MatriSys Bioscience Corporate Summary
Table 94. MatriSys Bioscience Living Biological Drugs Product Offerings
Table 95. MatriSys Bioscience Living Biological Drugs Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Living Biological Drugs Segment by Type in 2022
Figure 2. Living Biological Drugs Segment by Application in 2022
Figure 3. Global Living Biological Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Living Biological Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Living Biological Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Living Biological Drugs Revenue in 2022
Figure 8. By Type - Global Living Biological Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Living Biological Drugs Revenue Market Share, 2018-2030
Figure 10. By Region - Global Living Biological Drugs Revenue Market Share, 2018-2030
Figure 11. By Country - North America Living Biological Drugs Revenue Market Share, 2018-2030
Figure 12. US Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Living Biological Drugs Revenue Market Share, 2018-2030
Figure 16. Germany Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. France Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Living Biological Drugs Revenue Market Share, 2018-2030
Figure 24. China Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 28. India Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Living Biological Drugs Revenue Market Share, 2018-2030
Figure 30. Brazil Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Living Biological Drugs Revenue Market Share, 2018-2030
Figure 33. Turkey Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Living Biological Drugs Revenue, (US$, Mn), 2018-2030
Figure 37. Ardeypharman Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Miyarisan Pharmaceutical Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Ferring Pharmaceuticals Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Seres Therapeutics Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Infant Bacterial Therapeutics Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Osel Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Takeda Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AOBiome Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Synlogic Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Finch Therapeutics Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Capsugel Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Jeneil Biotech Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. UAS Labs Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Biose Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Cerbios-Pharma Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Inpac Probiotics Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. NIZO Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Winclove Probiotics Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. BJP Laboratories Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Luina Bio Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. List Labs Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. MatriSys Bioscience Living Biological Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
